| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 154, Issue 5 2063-2074, Copyright © 1995 by American Association of Immunologists
ARTICLES |
PF Mixter, JQ Russell, FH Durie and RC Budd
Department of Medicine, University of Vermont College of Medicine, Burlington 05405.
The CD4-CD8- T cells that accumulate in lpr/lpr mice have previously expressed CD8, on the basis of studies of CD8 alpha gene demethylation. The actual requirement for CD8 interaction with class I MHC molecules to promote the appearance of CD4-CD8- T cells in lpr/lpr mice has also been suggested. To examine this point in more detail, the lpr mutation was bred onto a beta 2-microglobulin-deficient background (beta 2-m-/- ). C57BL/6 (B6) mice homozygous for both the lpr mutation of the fas gene and inactivation of the beta 2-m gene (beta 2-m-/- lpr/lpr) develop less alpha beta T cell lymphadenopathy than the parental B6 lpr/lpr strain. This is caused by the near absence of CD8+ T cells and a considerable reduction in CD4-CD8- T cells, revealing an important role for positive selection on class I MHC molecules during the ontogeny of lpr CD4-CD8- T cells. Although absolute numbers of peripheral T cells are decreased in beta 2-m-/- lpr/lpr mice, they manifest a B cell lymphadenopathy with age. beta 2-m-/- lpr/lpr mice display only subtle indications of autoimmune disease with age, compared with parental B6 (beta 2-m+/+)lpr/lpr mice. These include limited histopathologic stages of kidney disease and lack of proteinuria, despite the presence of serum anti-DNA Abs. Thus, absence of class I MHC-positive selection of CD8+ and CD4-CD8- TCR-alpha beta + cells limits the autoimmune diathesis observed in beta 2-m+/+ lpr/lpr mice.
This article has been cited by other articles:
|
|
 |
|
  A. Bristeau-Leprince, V. Mateo, A. Lim, A. Magerus-Chatinet, E. Solary, A. Fischer, F. Rieux-Laucat, and M.-L. Gougeon Human TCR {alpha}/{beta}+ CD4-CD8- Double-Negative T Cells in Patients with Autoimmune Lymphoproliferative Syndrome Express Restricted V{beta} TCR Diversity and Are Clonally Related to CD8+ T Cells J. Immunol., July 1, 2008; 181(1): 440 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Sekine, K. L. Graham, S. Zhao, M. K. Elliott, P. Ruiz, P. J. Utz, and G. S. Gilkeson Role of MHC-Linked Genes in Autoantigen Selection and Renal Disease in a Murine Model of Systemic Lupus Erythematosus J. Immunol., November 15, 2006; 177(10): 7423 - 7434. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Rubiolo, D. Piazzolla, K. Meissl, H. Beug, J. C. Huber, A. Kolbus, and M. Baccarini A balance between Raf-1 and Fas expression sets the pace of erythroid differentiation Blood, July 1, 2006; 108(1): 152 - 159. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Piazzolla, K. Meissl, L. Kucerova, C. Rubiolo, and M. Baccarini Raf-1 sets the threshold of Fas sensitivity by modulating Rok-{alpha} signaling J. Cell Biol., December 19, 2005; 171(6): 1013 - 1022. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Fortner and R. C. Budd The Death Receptor Fas (CD95/APO-1) Mediates the Deletion of T Lymphocytes Undergoing Homeostatic Proliferation J. Immunol., October 1, 2005; 175(7): 4374 - 4382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Dohrman, J. Q. Russell, S. Cuenin, K. Fortner, J. Tschopp, and R. C. Budd Cellular FLIP Long Form Augments Caspase Activity and Death of T Cells through Heterodimerization with and Activation of Caspase-8 J. Immunol., July 1, 2005; 175(1): 311 - 318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Priceputu, I. Rodrigue, P. Chrobak, J. Poudrier, T. W. Mak, Z. Hanna, C. Hu, D. G. Kay, and P. Jolicoeur The Nef-Mediated AIDS-Like Disease of CD4C/Human Immunodeficiency Virus Transgenic Mice Is Associated with Increased Fas/FasL Expression on T Cells and T-Cell Death but Is Not Prevented in Fas-, FasL-, Tumor Necrosis Factor Receptor 1-, or Interleukin-1{beta}-Converting Enzyme-Deficient or Bcl2-Expressing Transgenic Mice J. Virol., May 15, 2005; 79(10): 6377 - 6391. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Koltun, J. Nikolovski, K. Strong, D. Nikolic-Paterson, and W. D. Comper Mechanism of hypoalbuminemia in rodents Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1604 - H1610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. J. Brown, J. Hutcheson, E. Bickel, J. C. Scatizzi, L. D. Albee, G. K. Haines III, J. Eslick, K. Bradley, E. Taricone, and H. Perlman Fas Death Receptor Signaling Represses Monocyte Numbers and Macrophage Activation In Vivo J. Immunol., December 15, 2004; 173(12): 7584 - 7593. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Xiao, X. Zhang, K. K. Mann, S. Jodo, L. Li, W. N. Jarjour, A. Marshak-Rothstein, D. H. Sherr, and S.-T. Ju Changes in sensitivity of peripheral lymphocytes of autoimmune gld mice to FasL-mediated apoptosis reveal a mechanism for the preferential deletion of CD4-CD8-B220+ T cells Int. Immunol., May 1, 2004; 16(5): 759 - 766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Catterall, D. Stockwell, V. Marshall, A. Strasser, and J. Allison Autoimmune kidney disease and lymphadenopathy in NODlpr mice are not modified by deficiency in tumor necrosis factor receptor 1 or {beta}2-microglobulin Int. Immunol., June 1, 2003; 15(6): 679 - 690. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Roopenian, G. J. Christianson, T. J. Sproule, A. C. Brown, S. Akilesh, N. Jung, S. Petkova, L. Avanessian, E. Y. Choi, D. J. Shaffer, et al. The MHC Class I-Like IgG Receptor Controls Perinatal IgG Transport, IgG Homeostasis, and Fate of IgG-Fc-Coupled Drugs J. Immunol., April 1, 2003; 170(7): 3528 - 3533. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Chaudhury, S. Mehnaz, J. M. Robinson, W. L. Hayton, D. K. Pearl, D. C. Roopenian, and C. L. Anderson The Major Histocompatibility Complex-related Fc Receptor for IgG (FcRn) Binds Albumin and Prolongs Its Lifespan J. Exp. Med., February 3, 2003; 197(3): 315 - 322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Shi, C. Xie, D. Kreska, J. A. Richardson, and C. Mohan Genetic Dissection of SLE: SLE1 and FAS Impact Alternate Pathways Leading to Lymphoproliferative Autoimmunity J. Exp. Med., August 5, 2002; 196(3): 281 - 292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Trimble, K. A. Prince, G. A. Pestano, J. Daley, and H. Cantor Fas-Dependent Elimination of Nonselected CD8 Cells and lpr Disease J. Immunol., May 15, 2002; 168(10): 4960 - 4967. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. J. Kennedy, J. Q. Russell, N. Michail, and R. C. Budd Liver Damage by Infiltrating CD8+ T Cells Is Fas Dependent J. Immunol., December 1, 2001; 167(11): 6654 - 6662. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Schwarting, G. Tesch, K. Kinoshita, R. Maron, H. L. Weiner, and V. R. Kelley IL-12 Drives IFN-{gamma}-Dependent Autoimmune Kidney Disease in MRL-Faslpr Mice J. Immunol., December 15, 1999; 163(12): 6884 - 6891. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Tada, K. Nagasawa, A. Ho, F. Morito, S. Koarada, O. Ushiyama, N. Suzuki, A. Ohta, and T. W. Mak Role of the Costimulatory Molecule CD28 in the Development of Lupus in MRL/lpr Mice J. Immunol., September 15, 1999; 163(6): 3153 - 3159. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. F. Mixter, J. Q. Russell, G. J. Morrissette, C. Charland, D. Aleman-Hoey, and R. C. Budd A Model for the Origin of TCR-{alpha}{beta}+ CD4-CD8- B220+ Cells Based on High Affinity TCR Signals J. Immunol., May 15, 1999; 162(10): 5747 - 5756. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Q. Russell, G. J. Morrissette, M. Weidner, C. Vyas, D. Aleman-Hoey, and R. C. Budd Liver Damage Preferentially Results from CD8+ T Cells Triggered by High Affinity Peptide Antigens J. Exp. Med., September 21, 1998; 188(6): 1147 - 1157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Z. Mehal and I. N. Crispe TCR Ligation on CD8+ T Cells Creates Double-Negative Cells In Vivo J. Immunol., August 15, 1998; 161(4): 1686 - 1693. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Q. Russell, T. Mooney, P. L. Cohen, B. MacPherson, R. J. Noelle, and R. C. Budd Anti-CD40L Accelerates Renal Disease and Adenopathy in MRL-lpr Mice in Parallel with Decreased Thymocyte Apoptosis J. Immunol., July 15, 1998; 161(2): 729 - 739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. F. Davidson, T. Giese, and T. N. Fredrickson Spontaneous Development of Plasmacytoid Tumors in Mice with Defective Fas-Fas Ligand Interactions J. Exp. Med., June 1, 1998; 187(11): 1825 - 1838. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Liu, D. C. Roopenian, X. Zhou, G. J. Christianson, L. A. Diaz, D. D. Sedmak, and C. L. Anderson beta 2-microglobulin-deficient Mice Are Resistant to Bullous Pemphigoid J. Exp. Med., August 29, 1997; 186(5): 777 - 783. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Gilkeson, J. S. Mudgett, M. F. Seldin, P. Ruiz, A. A. Alexander, M. A. Misukonis, D. S. Pisetsky, and J. B. Weinberg Clinical and Serologic Manifestations of Autoimmune Disease in MRL-lpr/lpr Mice Lacking Nitric Oxide Synthase Type 2 J. Exp. Med., August 4, 1997; 186(3): 365 - 373. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
